Cholangiocarcinoma: treatment with sorafenib extended life expectancy to greater than four years

Cholangiocarcinomas arise from the epithelial cells of intrahepatic and extrahepatic bile ducts. They generally have a very poor prognosis. Many studies report a dismal median survival of approximately 6 months. In this case, we have a patient diagnosed with cholangiocarcinoma who has remarkably exc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of gastrointestinal oncology 2013-12, Vol.4 (4), p.E30-E32
Hauptverfasser: Chakunta, Hareesha Rao, Sunderkrishnan, Ravi, Kaplan, Mark A, Mostofi, Reza
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!